| Name | Lp-PLA2 -IN-1 |
|---|
| Description | inhibit Lp-PLA2 activity, processes for their preparation, to compositions containing them and to their use in the treatment of diseases associated with the activity of Lp-PLA2, for example atherosclerosis, Alzheimer's disease. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C21H17F5N4O3 |
|---|---|
| Molecular Weight | 468.38 |
| Storage condition | 2-8℃ |